Walter Karl Naumann, MD | |
105 Old Engle Mill Rd, Accident, MD 21520-2096 | |
(301) 746-8376 | |
(301) 746-8376 |
Full Name | Walter Karl Naumann |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 105 Old Engle Mill Rd, Accident, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508963810 | NPI | - | NPPES |
420691600 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | D0025759 (Maryland) | Primary |
207QG0300X | Family Medicine - Geriatric Medicine | D0025759 (Maryland) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Walter Karl Naumann, MD 105 Old Engle Mill Rd, Accident, MD 21520-2096 Ph: (301) 746-8376 | Walter Karl Naumann, MD 105 Old Engle Mill Rd, Accident, MD 21520-2096 Ph: (301) 746-8376 |
News Archive
According to an article in the June issue of the Journal of Bone and Joint Surgery (JBJS), Medicare patients - many who suffer from disabling arthritis of the hip and knee, among other age-related ailments - may end up facing an accessibility crisis to medical care.
Children from low income environments appear to have a higher risk of neurological impairment than those from more economically secure circumstances, according to researchers at the National Institutes of Health and other institutions. This neurological impairment appears to be distinct from the risk of cognitive and emotional delays known to accompany early-life poverty.
Home health care technology may provide one important solution to global concerns about how to sustain health care systems threatened by rising costs and manpower shortages, but such a change faces multiple obstacles to adoption, according to a new RAND Corporation study.
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Rep. Ed Whitfield, R-Ky., has introduced a bill in the House of Representatives that will set federal minimum education and certification standards in the Medicare program for the technical personnel providing, planning and delivering all medical imaging examinations and radiation therapy treatments.
› Verified 6 days ago